Skip to Main Content

Valeris Recruits Commercial Veteran Jeff Crowther to Lead Revenue Strategy

News

September 15, 2026

JEFFERSONVILLE, IN & MORRISVILLE, NC — September 15, 2026 — Valeris, an integrated commercialization partner helping life sciences companies connect market access, patient services, and commercial strategy, today announced that Jeff Crowther has joined as Chief Revenue Officer, reporting to Chief Commercial Officer Scott Filosi and becoming a member of the Valeris Executive Committee. The appointment reflects Valeris' continued investment in growth and innovation, with the patient kept at the center of every strategic decision.

Crowther brings more than 30 years of commercial leadership experience across marketing, sales, market access, business development, and operations, with therapeutic depth spanning oncology, hematology, CNS, gastroenterology, and infectious diseases. He joins Valeris from Syndax Pharmaceuticals, where he served as SVP, Commercial, building the oncology biotech's inaugural sales, marketing, clinical educator, and training functions ahead of the launch of its first two first-in-class assets. Earlier in his career, Crowther was a foundational commercial hire at SK Life Science, where he built the market development, marketing, sales, and training functions behind XCOPRI, the most successful adult partial-onset seizure product launch in the U.S. in over a decade — delivered at the height of the COVID-19 pandemic. He began his career in Johnson & Johnson's pharmaceutical division.

"Jeff brings a proven record of building commercial organizations from the ground up and delivering results under real market pressure," said Scott Filosi, Chief Commercial Officer of Valeris. "His experience will strengthen our team both strategically and from an execution standpoint, as we continue to invest in growth and innovation, always in service of the patients our partners rely on us to support."

"I've spent my career helping companies build commercial organizations that deliver value at scale," said Crowther. "I witnessed Valeris’s value proposition come to life firsthand in my previous role; positively impacting patients as a seamless extension of an emerging commercial biotech. I’m thrilled to be a member of a leadership team committed to transforming the patient experience and I’m confident that we’ll do so, ultimately becoming an indispensable business partner to the organizations we support.”

About Valeris
Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Jeffersonville, Indiana and Morrisville, North Carolina. To learn more about Valeris, please visit www.valeris.com.

Please submit the form below to view this resource.

Maximize value across the product and patient journeys. Find out how.